Cheng Luo , Danxia Peng , Yanyan Li , Shuping Liu , Qiong Wu , Xuan Xu , Jie Wen
{"title":"Mannose phosphate isomerase-congenital disorder of glycosylation leads to asymptomatic hypoglycemia","authors":"Cheng Luo , Danxia Peng , Yanyan Li , Shuping Liu , Qiong Wu , Xuan Xu , Jie Wen","doi":"10.1016/j.ymgmr.2024.101162","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Mannose phosphate isomerase deficiency-congenital glycosylation disorders (MPI-CDG) is a rare autosomal recessive disorder caused by pathogenic variants in the <em>MPI</em> gene and characterized by digestive, hepatic, and endocrine-related symptoms. Herein, we reported a case of a 4-month-old baby with MPI-CDG confirmed by genetic testing.</div></div><div><h3>Case summary</h3><div>Based on the age of the child and the present clinical symptoms (feeding difficulties, intractable diarrhea, vomiting, hepatosplenomegaly, recurrent hypoglycemia, coagulation disorder, and hypoproteinemia under the premise of anti-infection therapy), congenital glycosylation disorder was suspected, which was then confirmed by genetic testing. Her father carried a heterozygous deletion variant of exons 1–2 of the <em>MPI</em> gene, while her mother carried a heterozygous variant of C. 422C > T variant. It was suspected that a biallelic pathogenic variant of the <em>MPI</em> gene caused the CDG.</div></div><div><h3>Conclusion</h3><div>MPI-CDG should be considered in infancy with unexplained hypoglycemia and recurrent digestive and endocrine system involvement. Also, if evident symptoms are present, a gene examination should be performed, as this could speed up the diagnosis assuring timely treatment.</div></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":"41 ","pages":"Article 101162"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Genetics and Metabolism Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214426924001150","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Mannose phosphate isomerase deficiency-congenital glycosylation disorders (MPI-CDG) is a rare autosomal recessive disorder caused by pathogenic variants in the MPI gene and characterized by digestive, hepatic, and endocrine-related symptoms. Herein, we reported a case of a 4-month-old baby with MPI-CDG confirmed by genetic testing.
Case summary
Based on the age of the child and the present clinical symptoms (feeding difficulties, intractable diarrhea, vomiting, hepatosplenomegaly, recurrent hypoglycemia, coagulation disorder, and hypoproteinemia under the premise of anti-infection therapy), congenital glycosylation disorder was suspected, which was then confirmed by genetic testing. Her father carried a heterozygous deletion variant of exons 1–2 of the MPI gene, while her mother carried a heterozygous variant of C. 422C > T variant. It was suspected that a biallelic pathogenic variant of the MPI gene caused the CDG.
Conclusion
MPI-CDG should be considered in infancy with unexplained hypoglycemia and recurrent digestive and endocrine system involvement. Also, if evident symptoms are present, a gene examination should be performed, as this could speed up the diagnosis assuring timely treatment.
背景甘露糖磷酸异构酶缺乏症-先天性糖基化障碍(MPI-CDG)是一种罕见的常染色体隐性遗传疾病,由MPI基因的致病变异引起,以消化系统、肝脏和内分泌相关症状为特征。病例摘要根据患儿的年龄和目前的临床症状(喂养困难、顽固性腹泻、呕吐、肝脾肿大、反复低血糖、凝血功能障碍、抗感染治疗前提下的低蛋白血症),怀疑患先天性糖基化障碍,后经基因检测证实。她的父亲携带 MPI 基因 1-2 外显子的杂合子缺失变异,母亲携带 C. 422C > T 变异。结论对于不明原因的低血糖、反复出现消化系统和内分泌系统受累的婴儿,应考虑MPI-CDG。此外,如果出现明显症状,应进行基因检查,因为这可以加快诊断,确保及时治疗。
期刊介绍:
Molecular Genetics and Metabolism Reports is an open access journal that publishes molecular and metabolic reports describing investigations that use the tools of biochemistry and molecular biology for studies of normal and diseased states. In addition to original research articles, sequence reports, brief communication reports and letters to the editor are considered.